RxDoctor Payments Data

Richard Price

Family Medicine · Harrisonville, MONPI 1043209166

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $16,096 of the $26,037 with a category attached, or 61.8%. Joimax, Inc. accounts for 66.4% of it on its own, with 49 other manufacturers making up the rest. 2025 is the largest year on record at $15,392, more than ten times the $1,449 reported in 2019. Among family medicine clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$26,037in general payments, 2019–2025

Across 492 payments — averaging $52.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Joimax, Inc.$17K
  • Jazz Pharmaceuticals Inc.$1K
  • AbbVie$993
  • AstraZeneca$927
  • Boehringer Ingelheim$771
  • Pfizer$750
  • plus $4K from 44 others

What the payments were for

  • Consulting fees$1,3165%
  • Travel & lodging$16,09662%
  • Food & beverage$7,87630%
  • Education$60%
  • Entertainment$7433%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$26,037 in reported general payments places this provider in the 95th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin228$252,500
MounjaroTirzepatide114$144,408
OzempicSemaglutide116$127,194
OfevNintedanib Esylate12$76,420
TrulicityDulaglutide64$71,719
RexultiBrexpiprazole29$45,415
EliquisApixaban34$37,854
CaplytaLumateperone Tosylate14$27,007
Trelegy ElliptaFluticasone/Umeclidin/Vilanter28$23,233
MyrbetriqMirabegron22$17,481
Breo ElliptaFluticasone/Vilanterol32$15,109
FarxigaDapagliflozin Propanediol12$14,869
JanuviaSitagliptin Phosphate13$13,560
ArexvyRsvpref3 Antigen/As01e/Pf42$11,448
XareltoRivaroxaban16$9,717

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Ofev$771$328,920240 claims
Lilly USA, LLCMounjaro, Trulicity$578$216,127178 claims
Novo NordiskOzempic$397$127,194116 claims
GSKTrelegy Ellipta, Breo Ellipta, Arexvy$146$49,790102 claims
PfizerEliquis, Premarin, Abrysvo$750$45,82958 claims
Otsuka America Pharmaceutical, Inc.Rexulti$132$45,41529 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$324$27,00714 claims
Astellas Pharma US IncMyrbetriq$16$17,48122 claims
AstraZenecaFarxiga$927$14,86912 claims
MerckJanuvia$375$13,56013 claims
Johnson & JohnsonXarelto$109$9,71716 claims
NovartisEntresto$83$6,45111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Harrisonville

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →